EUVIMED · CrossrefJournal
Obesity
ISSN 1930-7381 · Wiley
Latest articles
The Role of the Lactate/ GPR81 ‐p38 Pathway in Exercise‐Induced Regulation of White Adipose Tissue Browning
Effects of Controlled Diets High in and Free of Ultraprocessed Food on the Brain of Emerging Adults
Interrupting Prolonged Sitting Improves Glucose Regulation More Than Continuous Walking in Adults With Overweight/Obesity
Impact of Preoperative Weight Loss and Obesity Medications on Postoperative Weight Loss After Sleeve Gastrectomy
A Digital Intervention Reduces Childhood Obesity Risk Behaviors: Analysis of Secondary Outcomes of the Greenlight Plus RCT
Proteome‐Wide Genetic Study Identified ENTPD5 as a Candidate Target for Obesity‐Related MASLD
Wearable‐Derived Physical Activity Patterns in Preclinical and Clinical Obesity
Two‐Year Weight Loss With a Breath Biofeedback mHealth Program: A Real‐World Evidence Study
Connexin43 Links Bone Marrow Mesenchymal Stem Cells to Peripheral Adiposity in Female Mice Under HFD
Sex‐Specific Pharmacological Management of Obesity: Insufficient Attention
Response to “Sex‐Specific Pharmacological Management of Obesity: Insufficient Attention”
Correction to “Isocaloric High‐Fat Diet Decreases Motivation in the Absence of Obesity”
Direct and Indirect Effects of Historic Residential Redlining on Prevalence of Cardiometabolic Diseases via Food Access
Should Metabolic Bariatric Surgery Be Offered Routinely to People With Extreme Obesity?
GLP ‐1 Receptor Agonists and Substance Use Disorders in Older Adults With Type 2 Diabetes: A Target Trial Emulation
Weight Loss, Obesity Medication, and Risk of Obesity‐Associated Cancer: A Meta‐Analysis of Randomized Controlled Trials
The Uncharted Territory of the New Obesity Drugs in Users Without Obesity: A Sociomedical Perspective
Safety and Efficacy of Glucagon‐Like Peptide‐1 Receptor Agonists Use in Elderly People With Obesity—A Meta‐Analysis
Sex, Not Age, Predicts Weight Loss Outcomes With Tirzepatide: A Retrospective Analysis
Wernicke's Encephalopathy Following Semaglutide Treatment for Obesity: A Systematic PRISMA Review of Case‐Based Evidence
Extreme Obesity ( BMI ≥ 60 kg/m 2 ) Characterization up to and Beyond 80 kg/m 2 in 1,262,454 Bariatric Surgery Patients
Issue Information
Metabolic Surgery in the GLP ‐1 Era: Upfront Toll, Long‐Term Dividend
DXA ‐Measured Visceral Adipose Tissue and Accelerated Biological Aging in Middle‐Aged Adults
Increasing Obesity Severity Is Associated With Less Surgical Care in the United States
How Low Could Semaglutide Prices Fall? An Analysis of Production Cost and Implications for Global Access
Revisiting Motivation in Pediatric Weight Management: A Self‐Determination Perspective on the STARKIDS Cohort Findings
Response to: “Revisiting Motivation in Pediatric Weight Management: A Self‐Determination Perspective on the STARKIDS Cohort Findings”
Real‐World Effectiveness of Semaglutide and Tirzepatide Compared With Bariatric Surgery
Changes in Ultra‐Processed Food Intake During a Single‐Arm Behavioral Weight Management Intervention: A Secondary Analysis
EUVIMED